Related Experiment Video
Updated: Mar 21, 2026

07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
12.0K
[THE EFFECT OF PERINATAL HYPOXIA ON THE STRUCTURE OF BLOOD-BRAIN BARRIER IN RATS TREATED WITH SALIFEN]
Morfologiia (Saint Petersburg, Russia)
|May 5, 2016
Summary
Salifen treatment improved the blood-brain barrier's microvasculature in rats exposed to early-life hypoxia. This study highlights salifen's potential protective effects on endothelial cells following perinatal hypoxia.
Area of Science:
- Neuroscience
- Pharmacology
- Developmental Biology
Background:
- Perinatal hypoxia can negatively impact brain development and the blood-brain barrier (BBB).
- Understanding the BBB's response to early-life hypoxia is crucial for developing neuroprotective strategies.
- The drug salifen's effects on the BBB following hypoxia have not been extensively studied.
Purpose of the Study:
- To investigate the impact of salifen on the structural integrity of the blood-brain barrier (BBB) in Wistar rats.
- To evaluate salifen's efficacy in mitigating the adverse effects of early-postnatal hypoxia on the neocortex.
- To assess the compensatory-adaptive responses of the BBB elements to hypoxia with salifen treatment.
Main Methods:
- Wistar rats were divided into three groups: hypoxia with salifen treatment, hypoxia only, and intact controls.
- Light and electron microscopy were employed to examine BBB structural characteristics in the neocortex.
- Hypoxia was induced on postnatal Day 2, modeling human preterm pregnancy complications.
Main Results:
- Salifen treatment demonstrated a positive effect on the microvasculature following perinatal hypoxia.
- The drug notably improved the condition of endothelial cells within the BBB.
- Evidence suggests salifen actively participates in compensatory-adaptive reactions of the BBB to hypoxic stress.
Conclusions:
- Salifen exhibits protective properties against structural damage to the blood-brain barrier caused by early-postnatal hypoxia.
- The findings support the potential therapeutic application of salifen in conditions involving perinatal hypoxia.
- Further research into salifen's neuroprotective mechanisms and long-term effects is warranted.

